Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts

Chemistry and Biology

Volumn 9, Issue 5, 2002, Pages 629-638

  Malina, Jaroslav ^a   Kasparkova, Jana ^a   Natile, Giovanni ^b   Brabec, Viktor ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CISPLATIN DNA ADDUCT; CISPLATIN-DNA ADDUCT; DRUG DERIVATIVE; HIGH MOBILITY GROUP B1 PROTEIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; CHO CELL; DNA ADDUCT; DNA REPAIR; ENZYME SPECIFICITY; GEL MOBILITY SHIFT ASSAY; GENETICS; HAMSTER; HELA CELL; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; RAT; STEREOISOMERISM; SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CHO CELLS; CISPLATIN; CRICETINAE; DNA ADDUCTS; DNA REPAIR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HELA CELLS; HMGB1 PROTEIN; HUMANS; OLIGONUCLEOTIDE PROBES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RECOMBINANT PROTEINS; STEREOISOMERISM; SUBSTRATE SPECIFICITY;

EID: 0036015846     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(02)00134-5     Document Type: Article

References (72)

1. The coordination chemistry of platinum anticancer drugs and related compounds with DNA
2. Metal antitumor compounds: The mechanism of action of platinum complexes
3. 2{d(pGpG)}], the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA
4. Stereochemically controlled ligands influence atropisomerization of Pt(II) nucleotide complexes - Evidence for head-to-head and stable a head-to-tail atropisomers
5. Atropisomerization of cis-bis(5′GMP)-platinum(II)-diamine complexes with non-C2-symmetrical asymmetric diamine ligands containing NH groups directed to one side of the coordination plane
6. Recognition of platinum(II) amine complexes by nucleotides: Role of phosphate and carbonyl groups in ([N-15(3)]diethylenetriamine)-(guanosine 5′-monophosphate)
7. HMQC and H-1 and P-31 NMR-studies of platinum amine adducts of tetradeoxyribonucleotides: Relationship between P-31 shift and potential hydrogen-bonding interactions in pGpG moieties cross-linked by platinum
8. 2]
9. Reaction of unsymmetrically substituted derivatives of cisplatin with short oligodeoxynucleotides containing a -GpG- sequence: H-bonding interactions in pGpG moieties cross-linked by an asymmetric platinum complex enhancing the formation of one geometrical isomer
10. The relevance of hydrogen bonding in the mechanism of action of platinum antitumor compounds
11. Stereospecific hydrogen-bonding in mononucleotide adducts of platinum anticancer complexes in aqueous-solution
12. 2+ in aqueous-solution
13. Examination of antitumor activities of platinum complexes of 1,2-diaminocyclohexane isomers and their related complexes
14. Antitumor activity of 1,2-diamminocyclohexane-platinum complexes against Sarcoma 180 ascites form
15. Antitumor activity of platinum(II) complexes of 1,2-diaminocyclohexane isomers
16. Biophysical analysis of DNA modified by 1,2-diaminocyclohexane platinum(II) complexes
17. Relation of conformation to antitumor activity of platinum(II) complexes of 1,2-cyclohexanediamine and 2-(aminomethyl)cyclohexyl-amine isomers against leukemia P388
18. 2, oxalato, D-glucuronato and D-gluconato) and determination of their antitumor activity against leukemia L1210
19. Synthesis and antitumor activity of Pt(II) complexes containing 2,3-diaminopropanol isomers
20. Preparation of antitumour platinum(II) complexes of 1,2-diphenylethylenediamine isomers and their interactions with DNA and its purine moieties
21. Mutagenic activity of some platinum complexes with monodentate and bidentate amines
22. Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate diamine ring
23. Steric constraints inside the metal-coordination sphere as revealed by diastereotopic splitting of methylene protons
24. Synthesis, mutagenicity, binding to pBR-322 DNA and antitumor-activity of platinum(II) complexes with ethambutol
25. Preparation, characterization, cytotoxicity, and mutagenicity of a pair of enantiomeric platinum(II) complexes with the potential to bind enantioselectively to DNA
26. Preparation, DNA binding, and in vitro cytotoxicity of a pair of enantiomeric platinum(II) complexes, [(R)- and (S)-3-aminohexahydroazepine]dichloro-platinum(II). Crystal structure of the S enantiomer
27. Oxaliplatin in practice
28. 1,2-d(GpG) intrastrand cross-link formed by oxaliplatin with duplex DNA: A crystallographic study
29. 2.4 Å crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex
30. Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins
31. DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands
32. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins
33. Proteins that specifically recognize cisplatin-damaged DNA: A clue to anticancer activity of cisplatin
34. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins
35. The response of cellular proteins to cisplatin-damaged DNA
36. Repair of cisplatin-DNA adducts by the mammalian excision nuclease
37. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts
38. Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts
39. HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts
40. Intercalating residues determine the mode of HMG1 domains A and B binding to cisplatin-modified DNA
41. DNA sequence context and protein composition modulate HMG-domain protein recognition of ciplatin-modified DNA
42. DNA excision repair
43. DNA repair in eukaryotes
44. Molecular mechanism of nucleotide excision repair in mammalian cells
45. Repair of cisplatin-DNA adducts by protein extracts from human ovarian carcinoma
46. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours
47. Use of novel plasmid constructs to demonstrate fludarabine triphosphate inhibition of nucleotide excision repair of a site-specific 1,2-d(GpG) intrastrand cisplatin adduct
48. Human nucleotide excision nuclease removes thymine dimers from DNA by incising the 22nd phosphodiester bond 5′ and the 6th phosphodiester bond 3′ to the photodimer
49. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease
50. Structure, recognition, and processing of cisplatin-DNA adducts
51. Synthesis and structural characterization of platinum(II)-acyclovir complexes
52. Synthesis and structural characterisation of a new form of bis(acyclovir)(ethylenediamine)platinum(II): Correlation between the puckering of the carrier ligand and the canting of the nucleobases
53. DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link and the conformational and thermodynamic properties of duplex DNA
54. Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex
55. Consequences of HMG-domain binding to cisplatin-modified DNA
56. Proteins that bind to and mediate the biological activity of platinum anticancer drug-DNA adducts
57. Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin
58. HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts
59. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts
60. Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding
61. Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes
62. DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II)
63. Steric control of DNA interstrand cross-link sites of trans platinum complexes: Specificity can be dictated by planar nonleaving groups
64. Human DNA repair excision nuclease
65. Recognition of nonhybridizing base pairs during nucleotide excision repair of DNA
66. A role of basic residues and the putative intercalating phenylalanine of the HMG-1 box B in DNA supercoiling and binding to four-way DNA junctions
67. DNA bending by the chromosomal protein HMG1 and its high mobility group box domains. Effect of flanking sequences
68. Interaction of human-immunodeficiency-virus type-1 Tat-derived peptides with TAR RNA
69. DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract
70. Thermodynamics of ligand-nucleic acid interactions
71. Lac repressor binding to non-operator DNA: Detailed studies and a comparison of equilibrium and rate competition methods